Idiopathic intracranial hypertension (IIH) affects roughly 7 to 10 people per 100,000 in the general population, making it uncommon but far from unheard of. How rare it is for you personally depends heavily on your sex, age, and weight. For women between 15 and 44 who are obese, the incidence jumps to 22 per 100,000, roughly three times higher than the rate for all women in that age group (6.8 per 100,000).
Overall Incidence and Who It Affects Most
IIH occurs about five and a half times more often in women than in men. In the U.S. between 1997 and 2016, the median annual incidence was 1.97 per 100,000 for women and just 0.36 per 100,000 for men. The condition peaks in women aged 31 to 35, who have the highest prevalence of any age group.
At the extremes of the age spectrum, IIH is genuinely rare. Only about 2.25 children per 100,000 under age 10 are diagnosed, and the gender split in that age group is nearly even (45% female). Among adults over 51, prevalence drops to around 2 per 100,000.
IIH Is Becoming Less Rare
The condition is growing more common, and the trend is steep. Between 2002 and 2016 in the UK, the incidence of IIH rose by 108%. In a large U.S. database of 85 million patients, prevalence climbed from 7.3 per 100,000 in 2015 to 9.9 per 100,000 in 2022, a 35% increase in just seven years.
The sharpest growth is in adolescents. Among patients aged 11 to 17, the prevalence of IIH in females increased by 10 individuals per 100,000 between 2015 and 2022. This rise closely tracks obesity trends in the same age group. Over that same period, obesity prevalence among adolescents rose nearly 5%, with Black females (43.55%) and Hispanic females (38.24%) showing the highest rates.
Hospital visits tell an even more dramatic story. In the UK, annual hospital admissions for IIH went from 1,315 in 2002 to 7,123 in 2016, a 442% increase. The cost of IIH-related hospital care climbed from £9.2 million to £49.9 million during the same window.
Why Weight Is the Biggest Risk Factor
Body weight is the single strongest predictor of IIH. An elevated BMI is directly associated with a greater chance of being diagnosed, and the relationship scales with severity. Patients with a BMI above 40 are more likely to have severe swelling of the optic nerve at their first specialist visit. For every 10-point increase in BMI, the odds of severe vision loss rise by 1.4 times.
You don’t need to be severely obese for weight to matter. Even moderate weight gain of 5% to 15% of body weight increases the risk of developing IIH, regardless of whether you were already overweight. This means a 160-pound person gaining 8 to 24 pounds could meaningfully shift their risk profile.
Medications That Can Trigger It
Some cases of elevated brain pressure aren’t truly “idiopathic” (meaning without a known cause) but are triggered by medications. The most commonly implicated drugs include tetracycline antibiotics like minocycline and doxycycline, hormonal contraceptives, vitamin A derivatives such as isotretinoin (commonly used for acne), and steroid withdrawal. In one review of adverse reaction reports, 84% of cases occurred in women, and 69% of those female cases involved either a tetracycline antibiotic or a contraceptive. Combining tetracyclines with vitamin A or retinoids is considered particularly risky, and concurrent use is contraindicated.
How IIH Is Diagnosed
Because IIH mimics other conditions (it was historically called “pseudotumor cerebri,” meaning “false brain tumor”), diagnosis requires ruling out other explanations. The standard criteria require swelling of the optic nerve visible on eye exam, no other neurological abnormalities that would explain the symptoms, brain imaging that shows no structural cause, a spinal fluid pressure above 25 cm of water in adults (measured via lumbar puncture), and normal spinal fluid composition.
In cases where there’s no visible optic nerve swelling, diagnosis is still possible if certain eye movement problems are present, or if brain imaging shows at least three of a set of characteristic signs: an empty space where the pituitary gland sits, flattening at the back of the eyeball, fluid buildup around the optic nerves, or narrowing of the veins that drain blood from the brain.
The Risk of Permanent Vision Loss
The most serious consequence of IIH is damage to your eyesight. Roughly 5% to 15% of patients experience severe, permanent vision loss. Early hospital-based studies put the rate as high as 24%, but more recent outpatient studies, which capture a broader and less severe patient population, estimate 6% to 14%.
Beyond vision, many patients deal with persistent, disabling headaches that can be difficult to treat even when the underlying pressure is managed. More than half of patients in one large study had a single hospital episode and no further hospital care in the following year, but about 38% needed repeat hospital visits, suggesting that for a substantial minority, IIH is a chronic and recurring problem rather than a one-time diagnosis.